Inspection Record

Dr. Reddy's Laboratories Ltd. — FDA 483 Findings

US FDAInspected 2023-10-27Published 2023-11-29 9 findingsOther quality systemEquipment and facilityComplaint and recall handlingLaboratory and QC controlsComputer system validationQuality unit oversightProcess validation

Inspectors Saleem A Akhtar · Pratik S UpadhyayThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

Detenninations of confonnance to appropriate written specifications for acceptance are deficient for diug products.

2Equipment and facility

Buildings used in the manufacturing and processing ofa diug product are not maintained in a good state of repair.

3Complaint and recall handling

Procedures describing the handling of written and oral complaints related to diug products are deficiently written or followed.

4Laboratory and QC controls

The accuracy, sensitivity, specificity and reproducibility oftest methods have not been established.

5Other quality system

The use of instruments, apparatus and recording devices not meeting established specifications was observed.

6Computer system validation

Appropriate controls are not exercised over computers or related systems to assure that changes in master production and control records or other records are instituted only by authorized personnel.

7Quality unit oversight

The responsibilities and procedures applicable to the quality control unit are not fully followed.

8Equipment and facility

Equipment and utensils are not cleaned and maintained at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of the drng product.

9Process validation

Your fnm failed to establish adequate written procedures for production and process controls designed to assure that the diug products have the identity, strength, purity, and quality that they are purpo1ted or represented to possess.

About this record

Extracted automatically from the document US FDA published on 2023-11-29. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Dr. Reddy's Laboratories Ltd. company profile — full history US FDA documents, 2023 Go to Findings search